Ratings, Reviews Summary for EVISTA (ELI LILLY CO)

January 2024 Overall Patient opinion of EVISTA: 1.9 (not satisfied)

(based on 377 reviews )

Ratings by Age Group for EVISTA
Rating Scale from 1 (poor) to 5 (excellent)

Patient Age Group Number of Reviews Average Rating
Pediatric (Under 18)
Age 18 to 24
Age 25 to 34 1
Age 35 to 44 7 2.57
Age 45 to 54 98 1.76
Age 55 to 64 188 2.02
Age 65 to 74 66 1.84
Age 75 and up 14 2.07

Ratings by Sex for EVISTA
Rating Scale from 1 (poor) to 5 (excellent)

Patient Sex Number of Reviews Average Rating
Male 7 2.28
Female 368 1.92
Not Specified 2 4

Why EVISTA* (Raloxifene hydrochloride ) is Prescribed for Patients*

Patient opinion of EVISTA: not satisfied (average rating score: 1.97)

(based on 333 reviews - combined drugs with same active ingredient - see footnote for timeframe )

Top 10 Reasons for taking** EVISTA
(reported on Ask a Patient)

  Reason # of Ask a Patient Reviews
1Osteoporosis*77
2Osteopenia*73
3Bone loss11
4Breast hyperplasia2
5Breast cancer1

*Also included as reason for taking drug in FDA Adverse Events summary.

Top 20 Side Effects of EVISTA **
(reported on Ask a Patient)

  Side Effect # of Ask a Patient Reviews
1Muscle spasms95
2Hot flush89
3Pain*71
4Weight increased52
5Arthralgia*51
6Pain in extremity*38
7Insomnia36
8Hip fracture32
9Depression30
10Headache*26
11Alopecia22
12Nausea*19
13Anxiety19
14Night sweats18
15Disturbance in attention17
16Fatigue*17
17Back pain17
18Joint stiffness16
19Vision blurred15
20Paraesthesia15

*Important! This side effect is also associated with Adverse Event Reports (serious reaction); Also see charts in FDA Adverse Events summary.

Please click here for Safety Information and FDA Adverse Events summary for EVISTA

Click to go back to search results and EVISTA Reviews used as a basis for this report.

* Reviews for drugs with the same active ingredients have been aggregated in this analysis: Raloxifene hydrochloride (Raloxifene hcl, Raloxifene, Evista)

**Historical Analytics (through 2015) of AskaPatient Reviews Provided by Druginformer.com